Nelson Laboratories
Private Company
Funding information not available
Overview
Nelson Laboratories, founded in 1983, is a global leader in contract testing and advisory services for the medical device and pharmaceutical industries, ensuring product safety and regulatory compliance. As a core business unit of Sotera Health (NASDAQ: SHC), it operates a network of state-of-the-art laboratories and has expanded its capabilities through strategic acquisitions like Toxikon Europe and the integration of Regulatory Compliance Associates. The company's strategy is built on deep technical expertise, exceptional service, and end-to-end solutions, positioning it as a trusted partner for navigating complex development cycles and mitigating risk in a highly regulated market.
Technology Platform
An integrated ecosystem of state-of-the-art microbiological/analytical laboratories, proprietary testing methodologies (e.g., RapidCert™), digital client tools, and deep expert advisory services focused on product safety and regulatory compliance.
Opportunities
Risk Factors
Competitive Landscape
Competes with large, diversified CROs (Charles River, Labcorp) and specialized testing labs (NAMSA, Element). Nelson Labs differentiates through its integration within the Sotera Health sterilization ecosystem, deep standards-setting expertise, and a fully integrated testing-plus-advisory service model.